UNII 4550K0SC9B

SODIUM ACETATE

Unique Ingredient Identifier 4550K0SC9B is listed as a ingredient substance
Unii4550K0SC9B
Preferred Substance NameSODIUM ACETATE
Rn6131-90-4
NcitC47720
Rxcui237108
Pubchem23665404
Molecular FormulaC2H3O2.Na.3H2O
InchikeyAYRVGWHSXIMRAB-UHFFFAOYSA-M
SmilesO.O.O.[Na+].CC([O-])=O
Unii TypeINGREDIENT SUBSTANCE
RN6131-90-4
NCITC47720
RXCUI237108
PUBCHEM23665404
MFC2H3O2.Na.3H2O
INCHI KEYAYRVGWHSXIMRAB-UHFFFAOYSA-M
SMILESO.O.O.[Na+].CC([O-])=O

Alternate Names

Dosage Forms

UNII 4550K0SC9B SODIUM ACETATE is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,INFILTRATIONINJECTION0.38 %
AURICULAR (OTIC)SOLUTION0.075 %
AURICULAR (OTIC)SOLUTION, DROPS0.027 %
AURICULAR (OTIC)SUSPENSION0.042 %
AURICULAR (OTIC)SUSPENSION, LIQUID0.68 %
EXTRACORPOREALSOLUTION0.18 %
IM - IVINJECTION0.97 %
IM - IV - SCINJECTION0.65 %
IM - SCINJECTION0.2 %
INTERSTITIALINJECTION NA
INTRA-ARTICULARINJECTION ADJPH
INTRACAVITARYINJECTION NA
INTRADERMALINJECTION0.16 %
INTRALESIONALINJECTION ADJPH
INTRAMUSCULARINJECTION0.4 %W/V
INTRAOCULARSOLUTION0.39 %
INTRAPERITONEALINJECTION NA
INTRAPLEURALINJECTION NA
INTRASYNOVIALINJECTION ADJPH
INTRAVENOUSINJECTABLE0.2 mg/1mL
INTRAVENOUSINJECTABLE0.2 %
INTRAVENOUSINJECTION20.4 %
INTRAVENOUSINJECTION1.64 MG/ML
INTRAVENOUSINJECTION, SOLUTION0.2 MG/1ML
INTRAVENOUSINJECTION, SOLUTION0.04 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED12.5 %
INTRAVENOUSSOLUTION0.2 mg/1mL
INTRAVENOUSSOLUTION NA
INTRAVENOUSSOLUTION, INJECTION2 %
INTRAVENOUS INFUSIONINJECTION, SOLUTION0.04 %
INTRAVITREALSUSPENSION, INJECTION0.39 %
IV - SCINJECTION0.2 %
IV - SCLIQUID0.2 %
IV(INFUSION)INJECTABLE0.16 %
IV(INFUSION)INJECTION59.4 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED6.25 %
IV(INFUSION)SOLUTION, INJECTION0.68 %
NASALSOLUTION NA
NERVE BLOCKINJECTION0.38 %
OPHTHALMICEMULSION0.05 %
OPHTHALMICPOWDER, FOR SOLUTION0.39 %
OPHTHALMICSOLUTION1.25 %
OPHTHALMICSOLUTION, DROPS1.28 %
ORALCONCENTRATE NA
ORALPOWDER, FOR SOLUTION99.3 MG/1GM
ORALSOLUTION3400 MG/1000ML
ORALSOLUTION, INJECTION1.36 MG/1.7ML
ORALSOLUTION, SYRUP7.2 MG/5ML
ORALSYRUP21.45 MG/5ML
OTICSUSPENSION0.03 %
PARENTERALINJECTABLE0.16 %
PARENTERALINJECTION10.37 %
PARENTERALPOWDER, FOR INJECTION SOLUTION1.25 %
PHOTOPHERESISSOLUTION0.18 %
SOFT TISSUEINJECTION ADJPH
SUBCUTANEOUSINJECTABLE0.2 %
SUBCUTANEOUSINJECTION0.2 %
SUBCUTANEOUSLIQUID0.15 %
SUBCUTANEOUSSOLUTION0.023 %
SUBCUTANEOUSSOLUTION, INJECTION0.35 %
SUBMUCOSALSOLUTION, INJECTION0.08 %
TOPICALEMULSION, CREAM NA
TOPICALSOLUTION0.3 MG/1ML

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.